ArticlemSphere2026
A heterologous marker-free selection approach for CRISPR/Cas9-based gene editing in the malaria parasite
Eilidh Carrington, Daniel Ballmer, Igor Niederwieser, Basil T Thommen, Nicolas M B Brancucci, Till S Voss
Abstract read
In one paragraphArticle in mSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Eilidh CarringtonDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID 0000-0001-7419-0810 Daniel BallmerDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID 0000-0002-1966-0960 Igor NiederwieserDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
Basil T ThommenDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
Nicolas M B BrancucciDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
Till S VossDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID 0000-0002-1464-4988 Funding
European Molecular Biology Organization ALTF 920-2024Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 310030_184785,310030_220001Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 310030_200683
6 · The paper itselfAbstract
CRISPR/Cas9-based gene editing of the malaria parasite
Indexed as
CRISPR-Cas SystemsGene EditingPlasmodium falciparumAntimalarialsDrug ResistanceHumansMultienzyme ComplexesProtozoan ProteinsPyrimethamineTetrahydrofolate DehydrogenaseThymidylate SynthaseAntimalarialsMultienzyme ComplexesProtozoan ProteinsPyrimethamineTetrahydrofolate DehydrogenaseThymidylate Synthasethymidylate synthase-dihydrofolate reductaseCRISPR/Cas9malariaPlasmodium falciparum
Identifiers
PMID41885428
PMCPMC13123713
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390